Nature Communications (Feb 2021)

EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction

  • Jing Zhao,
  • Alan Blayney,
  • Xiaorong Liu,
  • Lauren Gandy,
  • Weihua Jin,
  • Lufeng Yan,
  • Jeung-Hoi Ha,
  • Ashley J. Canning,
  • Michael Connelly,
  • Chao Yang,
  • Xinyue Liu,
  • Yuanyuan Xiao,
  • Michael S. Cosgrove,
  • Sozanne R. Solmaz,
  • Yingkai Zhang,
  • David Ban,
  • Jianhan Chen,
  • Stewart N. Loh,
  • Chunyu Wang

DOI
https://doi.org/10.1038/s41467-021-21258-5
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 11

Abstract

Read online

Epigallocatechin gallate (EGCG) is a catechin flavonoid which induces apoptosis in cancerous cells, but the underlying molecular mechanisms remain poorly understood. Here authors use an interdisciplinary approach to show a direct interaction between EGCG and the tumor suppressor p53 and demonstrate that EGCG inhibits ubiquitination of p53 by MDM2.